Thomas Miller, Ph.D. Founder and COO

Dr. Miller is an expert in CD47 biology and inventor of the technology under development with PSTx.  During his cancer research fellowship at the NCI, he was awarded the Director's Innovation and NCI Technology Transfer Awards for his work on CD47 drug development.  In addition to a Ph.D. in chemistry from UCLA and cancer research fellowship, Dr. Miller also successfully led a team that developed, validated, and commercialized preclinical oncology drug development assays while at Meso Scale Discovery.  Dr. Miller brings a passion for and deep understanding of early stage drug discovery to the PSTx team as well as results driven people and project leadership skills.